Civic Intelligence

Peptide Therapeutics Foundation

990EZ • Fiscal year 2020 • EIN 26-3728931

Jan 01, 2020 to Dec 31, 2020 • Filed on Jun 15, 2021

9395 Cabot DriveSan Diego, CA 92126

(858) 657-1511

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

60th percentile

0.01x

Higher debt load relative to assets than 60% of similar nonprofits.

2020 filings • 501(c)3 • <$500k nonprofits • Source year 2020

Liabilities / Revenue

73rd percentile

0.06x

Higher debt load relative to revenue than 73% of similar nonprofits.

2020 filings • 501(c)3 • <$500k nonprofits • Source year 2020

Net Margin

32nd percentile

-5.9%

Higher net margin than 32% of similar nonprofits.

2020 filings • 501(c)3 • <$500k nonprofits • Source year 2020

Top Officer Pay

76th percentile

$0

Higher top officer pay than 76% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

2020 filings • 501(c)3 • <$500k nonprofits • Source year 2020

Asset Growth

42nd percentile

-0.0%

Faster asset growth than 42% of similar nonprofits.

2020 filings • 501(c)3 • <$500k nonprofits • Annualized from 2019 to 2020

Revenue Growth

15th percentile

-64%

Faster revenue growth than 15% of similar nonprofits.

2020 filings • 501(c)3 • <$500k nonprofits • Annualized from 2019 to 2020

Assets

Down

$442,709

Down $220 (-0.0%) from 2019

Net Assets

Down

$439,902

Down $2,596 (-0.6%) from 2019

Liabilities

Up

$2,807

Up $2,376 (+551%) from 2019

Revenue

Down

$43,680

Down $77,585 (-64%) from 2019

Expenses

Down

$46,276

Down $64,613 (-58%) from 2019

Net Income

Down

-$2,596

Down $12,972 (-125%) from 2019

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$600K$400K$200K$0Assets 2013: $321,273Liabilities 2013: $47,078Net Assets 2013: $274,1952013Assets 2014: $348,771Liabilities 2014: $49,919Net Assets 2014: $298,8522014Assets 2015: $389,214Liabilities 2015: $58,059Net Assets 2015: $331,1552015Assets 2016: $404,349Liabilities 2016: $58,620Net Assets 2016: $345,7292016Assets 2017: $478,564Liabilities 2017: $67,800Net Assets 2017: $410,7642017Assets 2018: $433,418Liabilities 2018: $1,296Net Assets 2018: $432,1222018Assets 2019: $442,929Liabilities 2019: $431Net Assets 2019: $442,4982019Assets 2020: $442,709Liabilities 2020: $2,807Net Assets 2020: $439,9022020Assets 2021: $373,700Liabilities 2021: $197Net Assets 2021: $373,5032021Assets 2022: $281,743Liabilities 2022: $500Net Assets 2022: $281,2432022Assets 2023: $286,944Net Assets 2023: $286,9442023Assets 2024: $335,263Net Assets 2024: $335,2632024

Highlighted filing

2020

Assets$442,709
Liabilities$2,807
Net Assets$439,902

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$200K$100K$0-$100KRevenue 2013: $122,329Expenses 2013: $101,707Net Income 2013: $20,6222013Revenue 2014: $137,675Expenses 2014: $113,018Net Income 2014: $24,6572014Revenue 2015: $142,758Expenses 2015: $110,455Net Income 2015: $32,3032015Revenue 2016: $136,200Expenses 2016: $121,626Net Income 2016: $14,5742016Revenue 2017: $172,574Expenses 2017: $107,539Net Income 2017: $65,0352017Revenue 2018: $127,978Expenses 2018: $106,620Net Income 2018: $21,3582018Revenue 2019: $121,265Expenses 2019: $110,889Net Income 2019: $10,3762019Revenue 2020: $43,680Expenses 2020: $46,276Net Income 2020: -$2,5962020Revenue 2021: $66,103Expenses 2021: $115,909Net Income 2021: -$49,8062021Revenue 2022: $110,022Expenses 2022: $129,463Net Income 2022: -$19,4412022Revenue 2023: $134,883Expenses 2023: $157,903Net Income 2023: -$23,0202023Revenue 2024: $174,477Expenses 2024: $144,680Net Income 2024: $29,7972024

Highlighted filing

2020

Revenue$43,680
Expenses$46,276
Net Income-$2,596
Jump To
Filing Snapshot
Filing Period
Jan 1, 2020 to Dec 31, 2020
Signed
Jun 15, 2021
Return Version
2020v4.0
Gross Receipts
$43,680
Mission and Program Overview

Mission

The mission of peptide therapeutics foundation is to provide and promote public and charitable educational and informational programs, materials, research and discussion in the medical scientific field of peptide science and technology.

Program Services

DescriptionGrantsExpenses
HOLD A PEPTIDE THERAPEUTICS SYMPOSIUM TO BRING TOGETHER WORLD LEADERS FROM ACADEMIA, THE BIOPHARMACEUTICAL INDUSTRY, CMOS, CROS, AND INVESTORS INTERESTED IN ALL ASPECTS OF PEPTIDE R&D, INCLUDING DRUG DISCOVERY, SAFETY AND TOXICOLOGY, CLINICAL DEVELOMENT, MANUFACTURING, PHARMACEUTICAL DEVELOPMENT, FORMULATION, DRUG DELIVERY AND REGULATORY AFFAIRS. THE ORGANIZATION ALSO PROVIDED 13 POSTDOCTORAL FELLOWS AND GRADUATE STUDENTS WITH FREE REGISTRATION TO THE SYMPOSIUM.-$46,276
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
NICK COX PHDAssociate Di-$0--
ADRIENNE DAY PHDFounder & Pr-$0--
ROBERT HAGOPIANDirector Busines-$0--
LUTZ JERMUTUSSenior Direc-$0--
ADAM MEZO PHDSr. Director-$0--
RIE SCHULTZ HANSEN PHDSVP & Chief-$0--
Filing and Contact Details

Filer

Filer Name
Peptide Therapeutics Foundation
EIN
26-3728931
Phone
8586571511
Address
9395 CABOT DRIVE, SAN DIEGO, CA 92126

Signing Officer

Name
Adrienne Day Phd
Title
Founder & Principal
Phone
8586571511
Signed
2021-06-15

Preparer

Firm
GOODSELL & COMPANY INC CPA'S
Address
2366 FRONT STREET, SAN DIEGO, CA 92101-1414
Preparer
Steven J Holc CPA
Phone
6192384343
Supplemental Narrative

Additional Explanations

Form 990-ez, Part I, Line 16

Expenses symposium expenses 41,975 foundation maintenance 3,051 total 45,026

Form 990-ez, Part II, Line 26

Accrued symposium expense 431 2,807

Form 990-ez, Part III

The mission of peptide therapeutics foundation is to provide and promote public and charitable educational and informational programs, materials, research and discussion in the medical scientific field of peptide science and technology.

Form 990-ez, Part III, Line 28

Hold a peptide therapeutics symposium to bring together world leaders from academia, the biopharmaceutical industry, cmos, cros, and investors interested in all aspects of peptide r&d, including drug discovery, safety and toxicology, clinical develoment, manufacturing, pharmaceutical development, formulation, drug delivery and regulatory affairs. The organization also provided 13 postdoctoral fellows and graduate students with free registration to the symposium.

Raw XML Appendix171 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
CompensationExplanation/CompensationExplanationGrp/PersonNm0NICK COX PHD
CompensationExplanation/CompensationExplanationGrp/PersonNm1ADRIENNE DAY PHD
CompensationExplanation/CompensationExplanationGrp/PersonNm2ROBERT HAGOPIAN
CompensationExplanation/CompensationExplanationGrp/PersonNm3LUTZ JERMUTUS
CompensationExplanation/CompensationExplanationGrp/PersonNm4ADAM MEZO PHD
CompensationExplanation/CompensationExplanationGrp/PersonNm5RIE SCHULTZ HANSEN PHD
IRS990EZ/ActivitiesNotPreviouslyRptInd0false
IRS990EZ/AddressChangeInd0X
IRS990EZ/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0THE ORGANIZATION
IRS990EZ/BooksInCareOfDetail/PhoneNum08586571511
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt04245 SORRENTO VALLEY BLVD
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0SAN DIEGO
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CA
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd092121
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt0442929
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt0442709
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd0false
IRS990EZ/ContributionsGiftsGrantsEtcAmt037480
IRS990EZ/DonorAdvisedFndsInd0false
IRS990EZ/EngagedInExcessBenefitTransInd0false
IRS990EZ/ExcessOrDeficitForYearAmt0-2596
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt01250
IRS990EZ/FiledScheduleAInd0true
IRS990EZ/ForeignFinancialAccountInd0false
IRS990EZ/ForeignOfficeInd0false
IRS990EZ/Form1120PolFiledInd0false
IRS990EZ/Form990TotalAssetsGrp/BOYAmt0442929
IRS990EZ/Form990TotalAssetsGrp/EOYAmt0442709
IRS990EZ/GrossReceiptsAmt043680
IRS990EZ/InfoInScheduleOPartIIIInd0X
IRS990EZ/InfoInScheduleOPartIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/LobbyingActivitiesInd0false
IRS990EZ/MadeLoansToFromOfficersInd0false
IRS990EZ/MethodOfAccountingAccrualInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt0442498
IRS990EZ/NetAssetsOrFundBalancesEOYAmt0439902
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt0442498
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt0439902
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt01.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt11.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt21.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt31.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt41.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt51.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0NICK COX PHD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1ADRIENNE DAY PHD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2ROBERT HAGOPIAN
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3LUTZ JERMUTUS
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm4ADAM MEZO PHD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm5RIE SCHULTZ HANSEN PHD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0ASSOCIATE DI
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1FOUNDER & PR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2DIR. BUSINES
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3SENIOR DIREC
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt4SR. DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt5SVP & CHIEF
IRS990EZ/OperateHospitalInd0false
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd0false
IRS990EZ/OrganizationHadUBIInd0false
IRS990EZ/OtherExpensesTotalAmt045026
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd0false
IRS990EZ/PrimaryExemptPurposeTxt0THE MISSION OF PEPTIDE THERAPEUTICS FOUNDATION IS TO PROVIDE AND PROMOTE PUBLIC AND CHARITABLE EDUCATIONAL AND INFORMATIONAL PROGRAMS, MATERIALS, RESEARCH AND DISCUSSION IN THE MEDICAL SCIENTIFIC FIELD OF PEPTIDE SCIENCE AND TECHNOLOGY.
IRS990EZ/ProgramServiceRevenueAmt06200
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0HOLD A PEPTIDE THERAPEUTICS SYMPOSIUM TO BRING TOGETHER WORLD LEADERS FROM ACADEMIA, THE BIOPHARMACEUTICAL INDUSTRY, CMOS, CROS, AND INVESTORS INTERESTED IN ALL ASPECTS OF PEPTIDE R&D, INCLUDING DRUG DISCOVERY, SAFETY AND TOXICOLOGY, CLINICAL DEVELOMENT, MANUFACTURING, PHARMACEUTICAL DEVELOPMENT, FORMULATION, DRUG DELIVERY AND REGULATORY AFFAIRS. THE ORGANIZATION ALSO PROVIDED 13 POSTDOCTORAL FELLOWS AND GRADUATE STUDENTS WITH FREE REGISTRATION TO THE SYMPOSIUM.
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt046276
IRS990EZ/ProhibitedTaxShelterTransInd0false
IRS990EZ/RelatedOrganizationCtrlEntInd0false
IRS990EZ/SchoolOperatingInd0false
IRS990EZ/StatesWhereCopyOfReturnIsFldCd0CA
IRS990EZ/SubjectToProxyTaxInd0false
IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt0431
IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt02807
IRS990EZ/TanningServicesProvidedInd0false
IRS990EZ/TotalExpensesAmt046276
IRS990EZ/TotalProgramServiceExpensesAmt046276
IRS990EZ/TotalRevenueAmt043680
IRS990EZ/TransactionWithControlEntInd0false
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0WWW.PEPTIDETHERAPEUTICS.ORG
IRS990ScheduleA/Form990ScheduleAPartVIGrp/ExplanationTxt0OTHER INCOME 3,492
IRS990ScheduleA/Form990ScheduleAPartVIGrp/FormAndLineReferenceDesc0PART III, LINE 12
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearAmt043680
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus1YearAmt089945
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus2YearsAmt089970
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus3YearsAmt0134940
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus4YearsAmt089940
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt0448475
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearAmt06200
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus1YearAmt031320
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus2YearsAmt035390
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus3YearsAmt037634
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus4YearsAmt046260
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/TotalAmt0156804
IRS990ScheduleA/InvestmentIncomeCYPct00.00000
IRS990ScheduleA/InvestmentIncomePYPct00.00000
IRS990ScheduleA/OtherIncome509Grp/CurrentTaxYearMinus2YearsAmt02618
IRS990ScheduleA/OtherIncome509Grp/CurrentTaxYearMinus3YearsAmt0874
IRS990ScheduleA/OtherIncome509Grp/TotalAmt03492
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportCY509Pct00.99430
IRS990ScheduleA/PublicSupportPY509Pct00.99500
IRS990ScheduleA/PublicSupportTotal509Amt0605279
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind0X
IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt049880
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt0121265
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt0125360
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt0172574
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt0136200
IRS990ScheduleA/Total509Grp/TotalAmt0605279
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt049880
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt0121265
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt0127978
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt0173448
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt0136200
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt0608771
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0EXPENSES SYMPOSIUM EXPENSES 41,975 FOUNDATION MAINTENANCE 3,051 TOTAL 45,026
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1ACCRUED SYMPOSIUM EXPENSE 431 2,807
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2THE MISSION OF PEPTIDE THERAPEUTICS FOUNDATION IS TO PROVIDE AND PROMOTE PUBLIC AND CHARITABLE EDUCATIONAL AND INFORMATIONAL PROGRAMS, MATERIALS, RESEARCH AND DISCUSSION IN THE MEDICAL SCIENTIFIC FIELD OF PEPTIDE SCIENCE AND TECHNOLOGY.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3HOLD A PEPTIDE THERAPEUTICS SYMPOSIUM TO BRING TOGETHER WORLD LEADERS FROM ACADEMIA, THE BIOPHARMACEUTICAL INDUSTRY, CMOS, CROS, AND INVESTORS INTERESTED IN ALL ASPECTS OF PEPTIDE R&D, INCLUDING DRUG DISCOVERY, SAFETY AND TOXICOLOGY, CLINICAL DEVELOMENT, MANUFACTURING, PHARMACEUTICAL DEVELOPMENT, FORMULATION, DRUG DELIVERY AND REGULATORY AFFAIRS. THE ORGANIZATION ALSO PROVIDED 13 POSTDOCTORAL FELLOWS AND GRADUATE STUDENTS WITH FREE REGISTRATION TO THE SYMPOSIUM.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990-EZ, PART I, LINE 16
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990-EZ, PART II, LINE 26
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990-EZ, PART III
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990-EZ, PART III, LINE 28
ReturnHeader/BuildTS02022-09-23 18:48:47Z
ReturnHeader/BusinessOfficerGrp/PersonNm0ADRIENNE DAY PHD
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0FOUNDER & PRINCIPAL
ReturnHeader/BusinessOfficerGrp/PhoneNum08586571511
ReturnHeader/BusinessOfficerGrp/SignatureDt02021-06-15
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0PEPTIDE THERAPEUTICS FOUNDATION
ReturnHeader/Filer/BusinessNameControlTxt0PEPT
ReturnHeader/Filer/EIN0263728931
ReturnHeader/Filer/PhoneNum08586571511
ReturnHeader/Filer/USAddress/AddressLine1Txt09395 CABOT DRIVE
ReturnHeader/Filer/USAddress/CityNm0SAN DIEGO
ReturnHeader/Filer/USAddress/StateAbbreviationCd0CA
ReturnHeader/Filer/USAddress/ZIPCd092126
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0331005644
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0GOODSELL & COMPANY INC CPA'S
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt02366 FRONT STREET
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0SAN DIEGO
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0CA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd0921011414
ReturnHeader/PreparerPersonGrp/PhoneNum06192384343
ReturnHeader/PreparerPersonGrp/PreparationDt02021-06-14
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0STEVEN J HOLC CPA
ReturnHeader/ReturnTs02021-06-14T11:29:35-05:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonFirstNm0ADRIENNE
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonLastNm0DAY PHD
ReturnHeader/TaxPeriodBeginDt02020-01-01
ReturnHeader/TaxPeriodEndDt02020-12-31
ReturnHeader/TaxYr02020

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings